A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the mullerian duct

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Baarends, W. M.
	Articles by et, al.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Baarends, W. M.
	Articles by et, al.


Social Bookmarking

	What's this?

Attisano, L., Wrana, J. L., Cheifetz, S. and Massague, J (1992). Novel activin receptors: Distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell 68, 97-108.[Medline]

Auffray, C. and Rougeon, F (1980). Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur. J. Biochem 107, 303-314.[Medline]

Behringer, R. R., Cate, R. L., Froelick, G. J., Palmiter, R. D. and Brinster, R. L (1990). Abnormal sexual development in transgenic mice chronically expressing mullerian inhibiting substance. Nature 345, 167-170.[Medline]

Blok, L. J., Themmen, A. P. N., Peters, A. H. F. M., Trapman, J., Baarends, W. M., Hoogerbrugge, J. W. and Grootegoed, J. A (1992). Transcriptional regulation of androgen receptor gene expression in Sertoli cells and other cell types. Mol. cell. Endocrinol 88, 153-164.[Medline]

Cate, R. L., Mattaliano, R. J., Hession, C., Tizard, R., Farber, N. M., Cheung, A., Ninfa, E. G., Frey, A. Z., Gash, D. J., Chow, E. P., Fisher, R. A., Bertonis, J. M., Torres, G., Wallner, B. P., Ramachandran, K. L., Ragin, R. C., Manganaro, T. F., Maclaughlin, D. T. and Donahoe, P. K (1986). Isolation of the bovine and human genes for mullerian inhibiting substance and expression of the human gene in animal cells. Cell 45, 685-698.[Medline]

Cheifetz, S., Weatherbee, J. A., Tsang, M. L., Anderson, J. K., Mole, J. E., Lucas, R. and Massague, J (1987). The transforming growth factor-system, a complex pattern of cross-reactive ligands and receptors. Cell 48, 409-415.[Medline]

Chen, R., Ebner, R. and Derynck, R (1993). Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-activities. Science 260, 1335-1338.[Abstract/Free Full Text]

de Winter, J. P., Themmen, A. P. N., Hoogerbrugge, J. W., Klaij, I. A., Grootegoed, J. A. and de Jong, F. H (1992). Activin receptor mRNA expression in rat testicular cell types. Mol. cell. Endocrinol 83, 1-.[Medline]

Donahoe, P. K., Ito, Y. and Hendren, W. H (1977). A graded organ culture assay for the detection of mullerian inhibiting substance. J. Surg. Res 23, 141-148.[Medline]

Ebner, R., Chen, R., Shum, L., Lawler, S., Zioncheck, T. F., Lee, A., Lopez, A. R. and Derynck, R (1993). Cloning of a type I TGF-receptor and its effect on TGF- binding to the type II receptor. Science 260, 1344-1348.[Abstract/Free Full Text]

Fort, Ph., Marty, L., Piechaczyk, M., El Sabrouty, S., Dani, Ch., Jeanteur, Ph. and Blanchard, J. M (1985). Various rat adult tissues express only one major mRNA species from the glyceraldehyde 3 phosphate dehydrogenase multigenic family. Nucl. Acids Res 13, 1431-4142.[Abstract/Free Full Text]

Georgi, L. L., Albert, P. S. and Riddle, D. L (1990). Daf-1, a C. elegans gene controlling dauer larva development encodes a novel receptor protein kinase. Cell 61, 635-645.[Medline]

Guerrier, D., Tran, D., Van der Winden, J. M., Hideux, S., Van Outryne, L., Legeai, L., Bouchard, M., van Vliet, G., DeLaet, M. H., Picard, J. Y., Kahn, A. and Josso, N (1989). The persistent mullerian dyct syndrome: a molecular approach. J. Clin. Endocrinol. Metab 68, 46-53.[Abstract/Free Full Text]

Grootegoed, J. A., Jansen R. and van der Molen, H. J (1986). Effect of glucose on ATP dephosphorylation in rat spermatids. J. Reprod. Fert 77, 99-107.[Abstract/Free Full Text]

Hanks, S. K., Quinn, A. M. and Hunter, T (1988). The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains. Science 241, 42-52.[Abstract/Free Full Text]

He, W. W., Gustafson, M. L., Hirobe, S. and Donahoe, P. K (1993). Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-type II receptor family. Dev. Dyn 196, 133-142.[Medline]

Heckert, L. L. and Griswold, M. D (1991). Expression of follicle-stimulating hormone receptor mRNA in rat testes and Sertoli cells. Molec. Endocrinol 5, 670-677.[Abstract/Free Full Text]

Hemmati-Brivanlou, A. and Melton, D. A (1992). A truncated activin receptor inhibits mesoderm induction and formation of axial structures in Xenopus embryos. Nature 359, 609-614.[Medline]

Hirobe, S., He, W., Lee, M. M. and Donahoe, P. K (1992). Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity. Endocrinology 131, 854-862.[Abstract/Free Full Text]

Josso, N., Picard, J. Y. and Tran, D (1977). The anti-mullerian hormone. Recent. Prog. Horm. Res 33, 117-160.

Josso, N (1992). Anti-Mullerian hormone and Sertoli cell function. Horm. Res 38, 2-.

Jost, A (1947). Recherches sur la differenciation sexuelle de l'embryon de lapin. Arch. Anat. Microsc. Morphol. Exp 36, 271-315.

Kay, G. F., Ashworth, A., Penny, G. D., Dunlop, M., Swift, S., Brockdorff, N. and Rastan, S (1991). A candidate spermatogenesis gene on the mouse Y chromosome is homologous to ubiquitin-activating enzyme E1. Nature 354, 586-489.

Knebelmann, B., Boussin, L., Guerrier, D., Legeai, L., Kahn, A., Josso, N. and Picard, J. Y (1991). Anti-Mullerian hormone Bruxelles: a non-sense mutation in the last exon of the anti-mullerian hormone gene associated with the persistent mullerian duct syndrome in three brothers. Proc. natl. Acad. Sci. USA 88, 3767-3771.[Abstract/Free Full Text]

Kozak, M (1987). An analysis of 5-noncoding sequences from 699 vertebrate messenger RNAs. Nucl. Acids Res 15, 8125-8148.[Abstract/Free Full Text]

Lee, M. M., Cate, R. L., Donahoe, P. K. and Waneck G. L (1992). Developmentally regulated polyadenylation of two discrete messenger ribonucleic acids for mullerian inhibiting substance. Endocrinology 130, 847-853.[Abstract/Free Full Text]

Lin, H. Y., Wang, X., Ng-Eaton, E., Weinberg, R. A. and Lodish, H. F (1992). Expression cloning of the TGF-type II receptor, a functional transmembrane serine/threonine kinase. Cell 68, 775-785.[Medline]

Lopez-Casillas, F., Wrana, J. L. and Massague, J (1993). Betaglycan presents ligand to the TGFsignalling receptor. Cell 73, 1435-1444.[Medline]

Mathews, L. S. and Vale, W. W (1991). Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 65, 973-982.[Medline]

Mitchell, M. J., Woods, D. R., Tucker, P. K., Opp, J. S. and Bishop, C. E (1991). Homology of a candidate spermatogenic gene from the mouse Y chromosome to the ubiquitin-activating enzyme E1. Nature 354, 483-486.[Medline]

Massague, J (1990). The transforming growth factor-family. Annu. Rev. Cell Biol 6, 597-641.

Munsterberg, A. and Lovell-Badge, R (1991). Expression of the mouse anti-mullerian hormone gene suggests a role in both male and female sexual differentiation. Development 113, 613-624.[Abstract]

Nakamura, T., Sugino K., Kurosawa, N., Sawai, M., Takio, K., Eto, Y., Iwashita, S., Muramatsu, M., Titani, K. and Sugino, H (1992). Isolation and characterization of activin receptor from mouse embryonal carcinoma cells. J. biol. Chem 267, 18924-18928.[Abstract/Free Full Text]

Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B. and Ehrlich, H. A (1988). Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239, 487-491.[Abstract/Free Full Text]

Sanger, F. S., Nicklen, S. and Coulson, A. R (1977). DNA sequencing with chain-terminating inhibitors. Proc. natl. Acad. Sci. USA 74, 5463-5467.[Abstract/Free Full Text]

Schubert, D., Kimura, H., LaCorbiere, M., Vaughan, J., Karr, D. and Fischer, W. H (1990). Activin is a nerve cell survival molecule. Nature 344, 868-870.[Medline]

Sive, H. L. and St John, T (1988). A simple subtractive hybridization technique employing photoactivatable biotin and phenol extraction. Nucl. Acids Res 16, 10937-.[Free Full Text]

Sprengel, R., Braun, T., Nikolics, K., Segaloff, D. L. and Seeburg., P. H (1990). The testicular receptor for follicle stimulating hormone: structure and functional expression of cloned cDNA. Molec. Endocrinol 4, 525-530.[Abstract/Free Full Text]

Themmen, A. P. N., Blok, L. J., Post, M., Baarends, W. M., Hoogerbrugge, J. W., Parmentier, M., Vassart, G. and Grootegoed, J. A (1991). Follitropin receptor down-regulation involves a cAMP-dependent post-transcriptional decrease of receptor mRNA expression. Mol. cell. Endocrinol 78, 7-.[Medline]

Thomsen G., Woolf, T., Whitman, M., Sokol, S., Vaughan, J., Vale, W. and Melton, D. A (1990). Activins are expressed early in Xenopus embryogenesis and can induce axial mesoderm and anterior structures. Cell 63, 485-493.[Medline]

Tran, D. and Josso, N (1982). Localization of anti-mullerian hormone in the rough endoplasmatic reticulum of the developing bovine Sertoli cell using immunocytochemistry with a monoclonal antibody. Endocrinology 111, 1562-1567.[Abstract/Free Full Text]

Trelstad, R. L., Hayashi, A., Hayashi, K. and Donahoe, P. K (1982). The epithelial-mesenchymal interface of the male rat mullerian duct: Loss of basement membrane integrity and ductal regression. Dev. Biol 92, 27-40.[Medline]

Tsuji, M., Shima, H., Yonemura, C. Y., Brody, J., Donahoe, P. K. andCunha, G. R (1992). Effect of human recombinant mullerian inhibiting substance on isolated epithelial and mesenchymal cells during mullerian duct regression in the rat. Endocrinology 131, 1481-1488.[Abstract/Free Full Text]

Vale, W., Rivier, C., Hsueh, A., Campen, C., Meunier, H., Bicsak, T., Vaughan, J., Corrigan, A., Bardin, W., Sauchenko, P., Petraglia, F., Yu, J., Plotsky, P., Spiess, J. and Rivier, J (1988). Chemical and biological characterization of the inhibin family of protein hormones. Recent Prog. Horm. Res 44, 1-34.

Vigier, B., Forest, M. G., Eychenne, B., Bezard, J., Garrigou, O., Robel, P. and Josso, N (1989). Anti-mullerian hormone produces endocrine sex reversal of fetal ovaries. Proc. natl. Acad. Sci. U. S. A 86, 3684-3688.[Abstract/Free Full Text]

von Heijne, G (1986). A new method for predicting signal sequence cleavage sites. Nucl. Acids Res 14, 4683-4690.[Abstract/Free Full Text]

Wang, X., Lin, H. Y., Ng-Eaton, E., Downward, J., Lodish, H. F. and Weinberg, R. A (1991). Expression cloning and characterization of the TGF-type III receptor. Cell 67, 797-805.[Medline]

Wrana, J. L., Attisano, L., C\207rcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X-F. and Massague J (1992). TGF-signals through a heteromeric protein kinase receptor complex. Cell 71, 1003-1014.[Medline]

Yu, J., Shao, L., Lemas, V., Yu, A. L., Vaughan, J., Rivier, J. and Vale, W (1987). Importance of FSH-releasing protein and inhibin in erythrodifferentiation. Nature 300, 765-767.

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati

Twitter What's this?

This article has been cited by other articles:

C. Belville, J.-D. Marechal, S. Pennetier, P. Carmillo, L. Masgrau, L. Messika-Zeitoun, J. Galey, G. Machado, D. Treton, J. Gonzales, et al.
Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport
Hum. Mol. Genet., August 15, 2009; 18(16): 3002 - 3013.
[Abstract] [Full Text] [PDF]

X. Wu, S. Wan, S. Pujar, M. E. Haskins, D. H. Schlafer, M. M. Lee, and V. N. Meyers-Wallen
A Single Base Pair Mutation Encoding a Premature Stop Codon in the MIS Type II Receptor Is Responsible for Canine Persistent Mullerian Duct Syndrome
J Androl, January 1, 2009; 30(1): 46 - 56.
[Abstract] [Full Text] [PDF]

E. Shiraishi, N. Yoshinaga, T. Miura, H. Yokoi, Y. Wakamatsu, S.-I. Abe, and T. Kitano
Mullerian Inhibiting Substance Is Required for Germ Cell Proliferation during Early Gonadal Differentiation in Medaka (Oryzias latipes)
Endocrinology, April 1, 2008; 149(4): 1813 - 1819.
[Abstract] [Full Text] [PDF]

J. Klattig, R. Sierig, D. Kruspe, B. Besenbeck, and C. Englert
Wilms' Tumor Protein Wt1 Is an Activator of the Anti-Mullerian Hormone Receptor Gene Amhr2
Mol. Cell. Biol., June 15, 2007; 27(12): 4355 - 4364.
[Abstract] [Full Text] [PDF]

X. Yin, S. Ouyang, W. Xu, X. Zhang, K. L. Fok, H. Y. Wong, J. Zhang, X. Qiu, S. Miao, H. C. Chan, et al.
YWK-II protein as a novel Go-coupled receptor for Mullerian inhibiting substance in cell survival
J. Cell Sci., May 1, 2007; 120(9): 1521 - 1528.
[Abstract] [Full Text] [PDF]

R. Pieretti-Vanmarcke, P. K. Donahoe, L. A. Pearsall, D. M. Dinulescu, D. C. Connolly, E. F. Halpern, M. V. Seiden, and D. T. MacLaughlin
Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer
PNAS, November 14, 2006; 103(46): 17426 - 17431.
[Abstract] [Full Text] [PDF]

T. T. Tran, D. L. Segev, V. Gupta, H. Kawakubo, G. Yeo, P. K. Donahoe, and S. Maheswaran
Mullerian Inhibiting Substance Regulates Androgen-Induced Gene Expression and Growth in Prostate Cancer Cells through a Nuclear Factor-{kappa}B-Dependent Smad-Independent Mechanism
Mol. Endocrinol., October 1, 2006; 20(10): 2382 - 2391.
[Abstract] [Full Text] [PDF]

S J. Lin, T. F Lerch, R. W Cook, T. S Jardetzky, and T. K Woodruff
The structural basis of TGF-{beta}, bone morphogenetic protein, and activin ligand binding.
Reproduction, August 1, 2006; 132(2): 179 - 190.
[Abstract] [Full Text] [PDF]

Q.-a. Yuan, H. H. Simmons, M. K. Robinson, M. Russeva, W. A. Marasco, and G. P. Adams
Development of engineered antibodies specific for the Mullerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer.
Mol. Cancer Ther., August 1, 2006; 5(8): 2096 - 2105.
[Abstract] [Full Text] [PDF]

S. Mazerbourg and A. J.W. Hsueh
Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands
Hum. Reprod. Update, July 1, 2006; 12(4): 373 - 383.
[Abstract] [Full Text] [PDF]

Y. Zhan, A. Fujino, D. T. MacLaughlin, T. F. Manganaro, P. P. Szotek, N. A. Arango, J. Teixeira, and P. K. Donahoe
Mullerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Mullerian duct regression
Development, June 15, 2006; 133(12): 2359 - 2369.
[Abstract] [Full Text] [PDF]

R. Pieretti-Vanmarcke, P. K. Donahoe, P. Szotek, T. Manganaro, M. K. Lorenzen, J. Lorenzen, D. C. Connolly, E. F. Halpern, and D. T. MacLaughlin
Recombinant Human Mullerian Inhibiting Substance Inhibits Long-term Growth of MIS Type II Receptor-Directed Transgenic Mouse Ovarian Cancers In vivo
Clin. Cancer Res., March 1, 2006; 12(5): 1593 - 1598.
[Abstract] [Full Text] [PDF]

S. Mazerbourg, K. Sangkuhl, C.-W. Luo, S. Sudo, C. Klein, and A. J. W. Hsueh
Identification of Receptors and Signaling Pathways for Orphan Bone Morphogenetic Protein/Growth Differentiation Factor Ligands Based on Genomic Analyses
J. Biol. Chem., September 16, 2005; 280(37): 32122 - 32132.
[Abstract] [Full Text] [PDF]

N. Josso, C. Belville, N. di Clemente, and J.-Y. Picard
AMH and AMH receptor defects in persistent Mullerian duct syndrome
Hum. Reprod. Update, July 1, 2005; 11(4): 351 - 356.
[Abstract] [Full Text] [PDF]

Y. Yin and L. Ma
Development of the Mammalian Female Reproductive Tract
J. Biochem., June 1, 2005; 137(6): 677 - 683.
[Abstract] [Full Text] [PDF]

V. Gupta, J. L. Carey, H. Kawakubo, A. Muzikansky, J. E. Green, P. K. Donahoe, D. T. MacLaughlin, and S. Maheswaran
Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model
PNAS, March 1, 2005; 102(9): 3219 - 3224.
[Abstract] [Full Text] [PDF]

E. J. Renaud, D. T. MacLaughlin, E. Oliva, B. R. Rueda, and P. K. Donahoe
Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance
PNAS, January 4, 2005; 102(1): 111 - 116.
[Abstract] [Full Text] [PDF]

P. Jeyasuria, Y. Ikeda, S. P. Jamin, L. Zhao, D. G. de Rooij, A. P. N. Themmen, R. R. Behringer, and K. L. Parker
Cell-Specific Knockout of Steroidogenic Factor 1 Reveals Its Essential Roles in Gonadal Function
Mol. Endocrinol., July 1, 2004; 18(7): 1610 - 1619.
[Abstract] [Full Text] [PDF]

C. J. Jorgez, M. Klysik, S. P. Jamin, R. R. Behringer, and M. M. Matzuk
Granulosa Cell-Specific Inactivation of Follistatin Causes Female Fertility Defects
Mol. Endocrinol., April 1, 2004; 18(4): 953 - 967.
[Abstract] [Full Text] [PDF]

C. Belville, H. Van Vlijmen, C. Ehrenfels, B. Pepinsky, A. R. Rezaie, J.-Y. Picard, N. Josso, N. d. Clemente, and R. L. Cate
Mutations of the Anti-Mullerian Hormone Gene in Patients with Persistent Mullerian Duct Syndrome: Biosynthesis, Secretion, and Processing of the Abnormal Proteins and Analysis Using a Three-Dimensional Model
Mol. Endocrinol., March 1, 2004; 18(3): 708 - 721.
[Abstract] [Full Text] [PDF]

S. Shimasaki, R. K. Moore, F. Otsuka, and G. F. Erickson
The Bone Morphogenetic Protein System In Mammalian Reproduction
Endocr. Rev., February 1, 2004; 25(1): 72 - 101.
[Abstract] [Full Text] [PDF]

A. Kobayashi, W. Shawlot, A. Kania, and R. R. Behringer
Requirement of Lim1 for female reproductive tract development
Development, February 1, 2004; 131(3): 539 - 549.
[Abstract] [Full Text] [PDF]

A. J. Pask, D. J. Whitworth, C.-A. Mao, K.-J. Wei, N. Sankovic, J. A. M. Graves, G. Shaw, M. B. Renfree, and R. R. Behringer
Marsupial Anti-Mullerian Hormone Gene Structure, Regulatory Elements, and Expression
Biol Reprod, January 1, 2004; 70(1): 160 - 167.
[Abstract] [Full Text] [PDF]

D. C. Connolly, R. Bao, A. Y. Nikitin, K. C. Stephens, T. W. Poole, X. Hua, S. S. Harris, B. C. Vanderhyden, and T. C. Hamilton
Female Mice Chimeric for Expression of the Simian Virus 40 TAg under Control of the MISIIR Promoter Develop Epithelial Ovarian Cancer
Cancer Res., March 15, 2003; 63(6): 1389 - 1397.
[Abstract] [Full Text] [PDF]

L. M. Roberts, J. A. Visser, and H. A. Ingraham
Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development
Development, March 5, 2003; 129(6): 1487 - 1496.
[Abstract] [Full Text] [PDF]

V. M. Laurich, A. M. Trbovich, F. H. O'Neill, C. P. Houk, P. M. Sluss, A. H. Payne, P. K. Donahoe, and J. Teixeira
Mullerian Inhibiting Substance Blocks the Protein Kinase A-Induced Expression of Cytochrome P450 17{alpha}-Hydroxylase/C17-20 Lyase mRNA in a Mouse Leydig Cell Line Independent of cAMP Responsive Element Binding Protein Phosphorylation
Endocrinology, September 1, 2002; 143(9): 3351 - 3360.
[Abstract] [Full Text] [PDF]

A. L. L. Durlinger, M. J. G. Gruijters, P. Kramer, B. Karels, H. A. Ingraham, M. W. Nachtigal, J. Th. J. Uilenbroek, J. A. Grootegoed, and A. P. N. Themmen
Anti-Mullerian Hormone Inhibits Initiation of Primordial Follicle Growth in the Mouse Ovary
Endocrinology, March 1, 2002; 143(3): 1076 - 1084.
[Abstract] [Full Text] [PDF]

A. L. L. Durlinger, M. J. G. Gruijters, P. Kramer, B. Karels, T. R. Kumar, M. M. Matzuk, U. M. Rose, F. H. de Jong, J. Th. J. Uilenbroek, J. A. Grootegoed, et al.
Anti-Mullerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary
Endocrinology, November 1, 2001; 142(11): 4891 - 4899.
[Abstract] [Full Text] [PDF]

J. Teixeira, S. Maheswaran, and P. K. Donahoe
Mullerian Inhibiting Substance: An Instructive Developmental Hormone with Diagnostic and Possible Therapeutic Applications
Endocr. Rev., October 1, 2001; 22(5): 657 - 674.
[Abstract] [Full Text] [PDF]

M. Dutertre, L. Gouedard, F. Xavier, W.-Q. Long, N. di Clemente, J.-Y. Picard, and R. Rey
Ovarian Granulosa Cell Tumors Express a Functional Membrane Receptor for Anti-Mullerian Hormone in Transgenic Mice
Endocrinology, September 1, 2001; 142(9): 4040 - 4046.
[Abstract] [Full Text] [PDF]

I. A. Hughes
Minireview: Sex Differentiation
Endocrinology, August 1, 2001; 142(8): 3281 - 3287.
[Abstract] [Full Text] [PDF]

J. A. Visser, R. Olaso, M. Verhoef-Post, P. Kramer, A. P. N. Themmen, and H. A. Ingraham
The Serine/Threonine Transmembrane Receptor ALK2 Mediates Mullerian Inhibiting Substance Signaling
Mol. Endocrinol., June 1, 2001; 15(6): 936 - 945.
[Abstract] [Full Text] [PDF]

T. R. Clarke, Y. Hoshiya, S. E. Yi, X. Liu, K. M. Lyons, and P. K. Donahoe
Mullerian Inhibiting Substance Signaling Uses a Bone Morphogenetic Protein (BMP)-Like Pathway Mediated by ALK2 and Induces Smad6 Expression
Mol. Endocrinol., June 1, 2001; 15(6): 946 - 959.
[Abstract] [Full Text] [PDF]

D. T. MacLaughlin, J. Teixeira, and P. K. Donahoe
Perspective: Reproductive Tract Development--New Discoveries and Future Directions
Endocrinology, June 1, 2001; 142(6): 2167 - 2172.
[Full Text] [PDF]

S. Nef and L. F. Parada
Hormones in male sexual development
Genes & Dev., December 15, 2000; 14(24): 3075 - 3086.
[Full Text]

S Allard, P Adin, L Gouedard, N di Clemente, N Josso, M. Orgebin-Crist, J. Picard, and F Xavier
Molecular mechanisms of hormone-mediated Mullerian duct regression: involvement of beta-catenin
Development, January 8, 2000; 127(15): 3349 - 3360.
[Abstract] [PDF]

A. L. L. Durlinger, P. Kramer, B. Karels, F. H. de Jong, J. Th. J. Uilenbroek, J. A. Grootegoed, and A. P. N. Themmen
Control of Primordial Follicle Recruitment by Anti-Mullerian Hormone in the Mouse Ovary
Endocrinology, December 1, 1999; 140(12): 5789 - 5796.
[Abstract] [Full Text]

J. Teixeira, D. J. Kehas, R. Antun, and P. K. Donahoe
Transcriptional regulation of the rat Mullerian inhibiting substance type II receptor in rodent Leydig cells
PNAS, November 23, 1999; 96(24): 13831 - 13838.
[Abstract] [Full Text] [PDF]

P. T. Masiakos, D. T. MacLaughlin, S. Maheswaran, J. Teixeira, A. F. Fuller Jr., P. C. Shah, D. J. Kehas, M. K. Kenneally, D. M. Dombkowski, T. U. Ha, et al.
Human Ovarian Cancer, Cell Lines, and Primary Ascites Cells Express the Human Mullerian Inhibiting Substance (MIS) Type II Receptor, Bind, and Are Responsive to MIS
Clin. Cancer Res., November 1, 1999; 5(11): 3488 - 3499.
[Abstract] [Full Text] [PDF]

J. Teixeira, E. Fynn-Thompson, A. H. Payne, and P. K. Donahoe
Mullerian-Inhibiting Substance Regulates Androgen Synthesis at the Transcriptional Level
Endocrinology, October 1, 1999; 140(10): 4732 - 4738.
[Abstract] [Full Text]

M. M. Lee, C. C. Seah, P. T. Masiakos, C. M. Sottas, F. I. Preffer, P. K. Donahoe, D. T. MacLaughlin, and M. P. Hardy
Mullerian-Inhibiting Substance Type II Receptor Expression and Function in Purified Rat Leydig Cells
Endocrinology, June 1, 1999; 140(6): 2819 - 2827.
[Abstract] [Full Text]

Y. Mishina, D. J. Whitworth, C. Racine, and R. R. Behringer
High Specificity of Mullerian-Inhibiting Substance Signaling in Vivo
Endocrinology, May 1, 1999; 140(5): 2084 - 2088.
[Abstract] [Full Text]

P. d. S. Barbara, B. Moniot, F. Poulat, B. Boizet, and P. Berta
Steroidogenic Factor-1 Regulates Transcription of the Human Anti-mullerian Hormone Receptor
J. Biol. Chem., November 6, 1998; 273(45): 29654 - 29660.
[Abstract] [Full Text] [PDF]

N. K. Arambepola, D. Bunick, and P. S. Cooke
Thyroid Hormone and Follicle-Stimulating Hormone Regulate Mullerian-Inhibiting Substance Messenger Ribonucleic Acid Expression in Cultured Neonatal Rat Sertoli Cells
Endocrinology, November 1, 1998; 139(11): 4489 - 4495.
[Abstract] [Full Text] [PDF]

J. A. Visser, A. McLuskey, M. Verhoef-Post, P. Kramer, J. A. Grootegoed, and A. P. N. Themmen
Effect of Prenatal Exposure to Diethylstilbestrol on Mullerian Duct Development in Fetal Male Mice
Endocrinology, October 1, 1998; 139(10): 4244 - 4251.
[Abstract] [Full Text] [PDF]

V. Rouiller-Fabre, S. Carmona, R. A. Merhi, R. Cate, R. Habert, and B. Vigier
Effect of Anti-Mullerian Hormone on Sertoli and Leydig Cell Functions in Fetal and Immature Rats
Endocrinology, March 1, 1998; 139(3): 1213 - 1220.
[Abstract] [Full Text] [PDF]

C. Racine, R. Rey, M. G. Forest, F. Louis, A. Ferre, I. Huhtaniemi, N. Josso, and N. di Clemente
Receptors for anti-Mullerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell�differentiation
PNAS, January 20, 1998; 95(2): 594 - 599.
[Abstract] [Full Text] [PDF]

C. M. HAQQ and P. K. DONAHOE
Regulation of Sexual Dimorphism in Mammals
Physiol Rev, January 1, 1998; 78(1): 1 - 33.
[Abstract] [Full Text] [PDF]

E. A. Catlin, V. C. Tonnu, R. G. Ebb, B. A. Pacheco, T. F. Manganaro, R. M. Ezzell, P. K. Donahoe, and J. Teixeira
Mullerian Inhibiting Substance Inhibits Branching Morphogenesis and Induces Apoptosis in Fetal Rat Lung
Endocrinology, February 1, 1997; 138(2): 790 - 796.
[Abstract] [Full Text] [PDF]

G Giuili, W. Shen, and H. Ingraham
The nuclear receptor SF-1 mediates sexually dimorphic expression of Mullerian Inhibiting Substance, in vivo
Development, January 5, 1997; 124(9): 1799 - 1807.
[Abstract] [PDF]

E. Faure, L. Gouedard, S. Imbeaud, R. Cate, J.-Y. Picard, N. Josso, and N. di Clemente
Mutant Isoforms of the Anti-Mullerian Hormone Type II Receptor Are Not Expressed at the Cell Membrane
J. Biol. Chem., November 29, 1996; 271(48): 30571 - 30575.
[Abstract] [Full Text] [PDF]

M. Ryden, T. Imamura, H. Jornvall, N. Belluardo, I. Neveu, M. Trupp, T. Okadome, P. ten Dijke, and C. F. Ibanez
A Novel Type I Receptor Serine-Threonine Kinase Predominantly Expressed in the Adult Central Nervous System
J. Biol. Chem., November 29, 1996; 271(48): 30603 - 30609.
[Abstract] [Full Text] [PDF]

Y Mishina, R Rey, M J Finegold, M M Matzuk, N Josso, R L Cate, and R R Behringer
Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation.
Genes & Dev., October 15, 1996; 10(20): 2577 - 2587.
[Abstract] [PDF]

D.�l. C. Eus�be, N. di Clemente, R. Rey, C. Pieau, B. Vigier, N. Josso, and J.-Y. Picard
Cloning and Expression of the Chick Anti-M�llerian Hormone Gene
J. Biol. Chem., March 1, 1996; 271(9): 4798 - 4804.
[Abstract] [Full Text] [PDF]

D. Whitworth, G Shaw, and M. Renfree
Gonadal sex reversal of the developing marsupial ovary in vivo and in vitro
Development, January 12, 1996; 122(12): 4057 - 4063.
[Abstract] [PDF]

J Kent, S. Wheatley, J. Andrews, A. Sinclair, and P Koopman
A male-specific role for SOX9 in vertebrate sex determination
Development, January 9, 1996; 122(9): 2813 - 2822.
[Abstract] [PDF]

T. Nohno, T. Ishikawa, T. Saito, K. Hosokawa, S. Noji, D. H. Wolsing, and J. S. Rosenbaum
Identification of a Human Type II Receptor for Bone Morphogenetic Protein-4 That Forms Differential Heteromeric Complexes with Bone Morphogenetic Protein Type I Receptors
J. Biol. Chem., September 22, 1995; 270(38): 22522 - 22526.
[Abstract] [Full Text] [PDF]

M. Kawabata, A. Chytil, and H. L. Moses
Cloning of a Novel Type II Serine/Threonine Kinase Receptor through Interaction with the Type I Transforming Growth Factor-beta Receptor
J. Biol. Chem., March 10, 1995; 270(10): 5625 - 5630.
[Abstract] [Full Text] [PDF]

L. Gouedard, Y.-G. Chen, L. Thevenet, C. Racine, S. Borie, I. Lamarre, N. Josso, J. Massague, and N. di Clemente
Engagement of Bone Morphogenetic Protein Type IB Receptor and Smad1 Signaling by Anti-Mullerian Hormone and Its Type II Receptor
J. Biol. Chem., September 1, 2000; 275(36): 27973 - 27978.
[Abstract] [Full Text] [PDF]

D. L. Segev, T. U. Ha, T. T. Tran, M. Kenneally, P. Harkin, M. Jung, D. T. MacLaughlin, P. K. Donahoe, and S. Maheswaran
Mullerian Inhibiting Substance Inhibits Breast Cancer Cell Growth through an NFkappa B-mediated Pathway
J. Biol. Chem., September 8, 2000; 275(37): 28371 - 28379.
[Abstract] [Full Text] [PDF]

T. U. Ha, D. L. Segev, D. Barbie, P. T. Masiakos, T. T. Tran, D. Dombkowski, M. Glander, T. R. Clarke, H. K. Lorenzo, P. K. Donahoe, et al.
Mullerian Inhibiting Substance Inhibits Ovarian Cell Growth through an Rb-independent Mechanism
J. Biol. Chem., November 17, 2000; 275(47): 37101 - 37109.
[Abstract] [Full Text] [PDF]

D. L. Segev, Y. Hoshiya, A. E. Stephen, M. Hoshiya, T. T. Tran, D. T. MacLaughlin, P. K. Donahoe, and S. Maheswaran
Mullerian Inhibiting Substance Regulates NFkappa B Signaling and Growth of Mammary Epithelial Cells in Vivo
J. Biol. Chem., July 13, 2001; 276(29): 26799 - 26806.
[Abstract] [Full Text] [PDF]

A. E. Stephen, P. T. Masiakos, D. L. Segev, J. P. Vacanti, P. K. Donahoe, and D. T. MacLaughlin
Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo
PNAS, March 13, 2001; 98(6): 3214 - 3219.
[Abstract] [Full Text] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Baarends, W. M.

Articles by et, al.

Search for Related Content

PubMed

PubMed Citation

Articles by Baarends, W. M.

Articles by et, al.

Social Bookmarking

What's this?

				X. Wu, S. Wan, S. Pujar, M. E. Haskins, D. H. Schlafer, M. M. Lee, and V. N. Meyers-Wallen A Single Base Pair Mutation Encoding a Premature Stop Codon in the MIS Type II Receptor Is Responsible for Canine Persistent Mullerian Duct Syndrome J Androl, January 1, 2009; 30(1): 46 - 56. [Abstract] [Full Text] [PDF]

				E. Shiraishi, N. Yoshinaga, T. Miura, H. Yokoi, Y. Wakamatsu, S.-I. Abe, and T. Kitano Mullerian Inhibiting Substance Is Required for Germ Cell Proliferation during Early Gonadal Differentiation in Medaka (Oryzias latipes) Endocrinology, April 1, 2008; 149(4): 1813 - 1819. [Abstract] [Full Text] [PDF]

				J. Klattig, R. Sierig, D. Kruspe, B. Besenbeck, and C. Englert Wilms' Tumor Protein Wt1 Is an Activator of the Anti-Mullerian Hormone Receptor Gene Amhr2 Mol. Cell. Biol., June 15, 2007; 27(12): 4355 - 4364. [Abstract] [Full Text] [PDF]

				X. Yin, S. Ouyang, W. Xu, X. Zhang, K. L. Fok, H. Y. Wong, J. Zhang, X. Qiu, S. Miao, H. C. Chan, et al. YWK-II protein as a novel Go-coupled receptor for Mullerian inhibiting substance in cell survival J. Cell Sci., May 1, 2007; 120(9): 1521 - 1528. [Abstract] [Full Text] [PDF]

				R. Pieretti-Vanmarcke, P. K. Donahoe, L. A. Pearsall, D. M. Dinulescu, D. C. Connolly, E. F. Halpern, M. V. Seiden, and D. T. MacLaughlin Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer PNAS, November 14, 2006; 103(46): 17426 - 17431. [Abstract] [Full Text] [PDF]

				T. T. Tran, D. L. Segev, V. Gupta, H. Kawakubo, G. Yeo, P. K. Donahoe, and S. Maheswaran Mullerian Inhibiting Substance Regulates Androgen-Induced Gene Expression and Growth in Prostate Cancer Cells through a Nuclear Factor-{kappa}B-Dependent Smad-Independent Mechanism Mol. Endocrinol., October 1, 2006; 20(10): 2382 - 2391. [Abstract] [Full Text] [PDF]

				S J. Lin, T. F Lerch, R. W Cook, T. S Jardetzky, and T. K Woodruff The structural basis of TGF-{beta}, bone morphogenetic protein, and activin ligand binding. Reproduction, August 1, 2006; 132(2): 179 - 190. [Abstract] [Full Text] [PDF]

				Q.-a. Yuan, H. H. Simmons, M. K. Robinson, M. Russeva, W. A. Marasco, and G. P. Adams Development of engineered antibodies specific for the Mullerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer. Mol. Cancer Ther., August 1, 2006; 5(8): 2096 - 2105. [Abstract] [Full Text] [PDF]

				S. Mazerbourg and A. J.W. Hsueh Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands Hum. Reprod. Update, July 1, 2006; 12(4): 373 - 383. [Abstract] [Full Text] [PDF]

				Y. Zhan, A. Fujino, D. T. MacLaughlin, T. F. Manganaro, P. P. Szotek, N. A. Arango, J. Teixeira, and P. K. Donahoe Mullerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Mullerian duct regression Development, June 15, 2006; 133(12): 2359 - 2369. [Abstract] [Full Text] [PDF]

				R. Pieretti-Vanmarcke, P. K. Donahoe, P. Szotek, T. Manganaro, M. K. Lorenzen, J. Lorenzen, D. C. Connolly, E. F. Halpern, and D. T. MacLaughlin Recombinant Human Mullerian Inhibiting Substance Inhibits Long-term Growth of MIS Type II Receptor-Directed Transgenic Mouse Ovarian Cancers In vivo Clin. Cancer Res., March 1, 2006; 12(5): 1593 - 1598. [Abstract] [Full Text] [PDF]

				S. Mazerbourg, K. Sangkuhl, C.-W. Luo, S. Sudo, C. Klein, and A. J. W. Hsueh Identification of Receptors and Signaling Pathways for Orphan Bone Morphogenetic Protein/Growth Differentiation Factor Ligands Based on Genomic Analyses J. Biol. Chem., September 16, 2005; 280(37): 32122 - 32132. [Abstract] [Full Text] [PDF]

				N. Josso, C. Belville, N. di Clemente, and J.-Y. Picard AMH and AMH receptor defects in persistent Mullerian duct syndrome Hum. Reprod. Update, July 1, 2005; 11(4): 351 - 356. [Abstract] [Full Text] [PDF]

				Y. Yin and L. Ma Development of the Mammalian Female Reproductive Tract J. Biochem., June 1, 2005; 137(6): 677 - 683. [Abstract] [Full Text] [PDF]

				V. Gupta, J. L. Carey, H. Kawakubo, A. Muzikansky, J. E. Green, P. K. Donahoe, D. T. MacLaughlin, and S. Maheswaran Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model PNAS, March 1, 2005; 102(9): 3219 - 3224. [Abstract] [Full Text] [PDF]

				E. J. Renaud, D. T. MacLaughlin, E. Oliva, B. R. Rueda, and P. K. Donahoe Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance PNAS, January 4, 2005; 102(1): 111 - 116. [Abstract] [Full Text] [PDF]

				P. Jeyasuria, Y. Ikeda, S. P. Jamin, L. Zhao, D. G. de Rooij, A. P. N. Themmen, R. R. Behringer, and K. L. Parker Cell-Specific Knockout of Steroidogenic Factor 1 Reveals Its Essential Roles in Gonadal Function Mol. Endocrinol., July 1, 2004; 18(7): 1610 - 1619. [Abstract] [Full Text] [PDF]

				C. J. Jorgez, M. Klysik, S. P. Jamin, R. R. Behringer, and M. M. Matzuk Granulosa Cell-Specific Inactivation of Follistatin Causes Female Fertility Defects Mol. Endocrinol., April 1, 2004; 18(4): 953 - 967. [Abstract] [Full Text] [PDF]

				C. Belville, H. Van Vlijmen, C. Ehrenfels, B. Pepinsky, A. R. Rezaie, J.-Y. Picard, N. Josso, N. d. Clemente, and R. L. Cate Mutations of the Anti-Mullerian Hormone Gene in Patients with Persistent Mullerian Duct Syndrome: Biosynthesis, Secretion, and Processing of the Abnormal Proteins and Analysis Using a Three-Dimensional Model Mol. Endocrinol., March 1, 2004; 18(3): 708 - 721. [Abstract] [Full Text] [PDF]

				S. Shimasaki, R. K. Moore, F. Otsuka, and G. F. Erickson The Bone Morphogenetic Protein System In Mammalian Reproduction Endocr. Rev., February 1, 2004; 25(1): 72 - 101. [Abstract] [Full Text] [PDF]

				A. Kobayashi, W. Shawlot, A. Kania, and R. R. Behringer Requirement of Lim1 for female reproductive tract development Development, February 1, 2004; 131(3): 539 - 549. [Abstract] [Full Text] [PDF]

				A. J. Pask, D. J. Whitworth, C.-A. Mao, K.-J. Wei, N. Sankovic, J. A. M. Graves, G. Shaw, M. B. Renfree, and R. R. Behringer Marsupial Anti-Mullerian Hormone Gene Structure, Regulatory Elements, and Expression Biol Reprod, January 1, 2004; 70(1): 160 - 167. [Abstract] [Full Text] [PDF]

				D. C. Connolly, R. Bao, A. Y. Nikitin, K. C. Stephens, T. W. Poole, X. Hua, S. S. Harris, B. C. Vanderhyden, and T. C. Hamilton Female Mice Chimeric for Expression of the Simian Virus 40 TAg under Control of the MISIIR Promoter Develop Epithelial Ovarian Cancer Cancer Res., March 15, 2003; 63(6): 1389 - 1397. [Abstract] [Full Text] [PDF]

				L. M. Roberts, J. A. Visser, and H. A. Ingraham Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development Development, March 5, 2003; 129(6): 1487 - 1496. [Abstract] [Full Text] [PDF]

				V. M. Laurich, A. M. Trbovich, F. H. O'Neill, C. P. Houk, P. M. Sluss, A. H. Payne, P. K. Donahoe, and J. Teixeira Mullerian Inhibiting Substance Blocks the Protein Kinase A-Induced Expression of Cytochrome P450 17{alpha}-Hydroxylase/C17-20 Lyase mRNA in a Mouse Leydig Cell Line Independent of cAMP Responsive Element Binding Protein Phosphorylation Endocrinology, September 1, 2002; 143(9): 3351 - 3360. [Abstract] [Full Text] [PDF]

				A. L. L. Durlinger, M. J. G. Gruijters, P. Kramer, B. Karels, H. A. Ingraham, M. W. Nachtigal, J. Th. J. Uilenbroek, J. A. Grootegoed, and A. P. N. Themmen Anti-Mullerian Hormone Inhibits Initiation of Primordial Follicle Growth in the Mouse Ovary Endocrinology, March 1, 2002; 143(3): 1076 - 1084. [Abstract] [Full Text] [PDF]

				J. Teixeira, S. Maheswaran, and P. K. Donahoe Mullerian Inhibiting Substance: An Instructive Developmental Hormone with Diagnostic and Possible Therapeutic Applications Endocr. Rev., October 1, 2001; 22(5): 657 - 674. [Abstract] [Full Text] [PDF]

				M. Dutertre, L. Gouedard, F. Xavier, W.-Q. Long, N. di Clemente, J.-Y. Picard, and R. Rey Ovarian Granulosa Cell Tumors Express a Functional Membrane Receptor for Anti-Mullerian Hormone in Transgenic Mice Endocrinology, September 1, 2001; 142(9): 4040 - 4046. [Abstract] [Full Text] [PDF]

				I. A. Hughes Minireview: Sex Differentiation Endocrinology, August 1, 2001; 142(8): 3281 - 3287. [Abstract] [Full Text] [PDF]

				J. A. Visser, R. Olaso, M. Verhoef-Post, P. Kramer, A. P. N. Themmen, and H. A. Ingraham The Serine/Threonine Transmembrane Receptor ALK2 Mediates Mullerian Inhibiting Substance Signaling Mol. Endocrinol., June 1, 2001; 15(6): 936 - 945. [Abstract] [Full Text] [PDF]